Myriad Genetics' Crescendo Bioscience Offers New Clinical Data on Vectra(R) DA at ACR
November 19, 2014 at 07:07 AM EST
Crescendo Bioscience, a wholly-owned subsidiary of Myriad Genetics, Inc. (Nasdaq: MYGN), today presented new data that showed Vectra^® ...